Status: Recruiting
A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study)
The goal of this clinical trial is to learn if the drug BMS-986368 works to treat post stroke spasticity in adults who have had a stroke. BMS-986368 is a designed to increase natural compounds in the body that may help calm nerves that cause muscles to be tight or spasm. The study will also learn about the safety of drug BMS-986368
Participants needed: 42
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Alberto EsquenaziUpdated: Jul 29, 2026Locations: 1
Eligibility criteria
Ischemic or hemorrhagic stroke diagnosis 4 to 18 months prior to enrollment. [+5]
Participants must not have any concomitant disease or disorder that has symptoms... [+4]